Symbols / TELO Stock $1.40 -3.45% Telomir Pharmaceuticals, Inc.

Healthcare • Biotechnology • United States • NCM
TELO (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Erez Aminov
Exch · Country NCM · United States
Market Cap 96.28M
Enterprise Value 43.04M
Income -10.41M
Sales —
FCF (ttm) -86.57K
Book/sh 0.17
Cash/sh 0.21
Employees —
Insider 10d —
IPO Feb 09, 2024
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -5.00
PEG —
P/S —
P/B 8.14
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio 5.10
Current Ratio 5.14
Debt/Eq 8.01
LT Debt/Eq —
EPS (ttm) -0.33
EPS next Y -0.28
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2025-11-10
Earnings (prior) 2025-11-10
ROA -152.03%
ROE -3.18%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 68.77M
Shs Float 19.03M
Insider Own 70.22%
Instit Own 6.67%
Short Float 5.00%
Short Ratio 12.95
Short Interest 1.04M
52W High 3.10
vs 52W High -54.84%
52W Low 1.05
vs 52W Low 33.33%
Beta -0.73
Impl. Vol. —
Rel Volume 26.24
Avg Volume 98.10K
Volume 2.57M
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $1.45
Price $1.40
Change -3.45%
About

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.40
Latest analyst target
3. DCF / Fair value
$-0.02
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.40
Low
—
High
—
Mean
—
News
RSS: Latest TELO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2024-08-19 AMINOV EREZ Chief Executive Officer — 400 $6.01 $2,442
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
10.54
-13.91%
12.24
+210.55%
3.94
+361.52%
0.85
Research And Development
2.44
+8.96%
2.24
+41.99%
1.57
+88.95%
0.83
Selling General And Administration
8.10
-15.91%
9.64
+1505.54%
0.60
+2766.11%
0.02
General And Administrative Expense
8.10
-15.91%
9.64
+1505.54%
0.60
+2766.11%
0.02
Other Gand A
8.10
-15.91%
9.64
+1505.54%
0.60
+2766.11%
0.02
Other Operating Expenses
—
0.37
-79.04%
1.77
—
Total Expenses
10.54
-13.91%
12.24
+210.55%
3.94
+361.52%
0.85
Operating Income
-10.54
+13.91%
-12.24
-210.55%
-3.94
-361.52%
-0.85
EBITDA
-10.41
+14.61%
-12.19
-6.70%
-11.43
-1238.04%
-0.85
Normalized EBITDA
-10.41
+14.61%
-12.19
-209.34%
-3.94
-361.52%
-0.85
EBIT
-10.41
+14.61%
-12.19
-6.70%
-11.43
-1238.04%
-0.85
Total Unusual Items
—
0.00
+100.00%
-7.49
0.00
Total Unusual Items Excluding Goodwill
—
0.00
+100.00%
-7.49
0.00
Special Income Charges
—
0.00
+100.00%
-7.49
0.00
Other Special Charges
—
—
7.49
—
Net Income
-10.41
+37.01%
-16.53
-26.48%
-13.07
-1430.40%
-0.85
Pretax Income
-10.41
+37.01%
-16.53
-26.48%
-13.07
-1430.40%
-0.85
Net Non Operating Interest Income Expense
0.13
+102.93%
-4.29
-161.13%
-1.64
0.00
Interest Expense Non Operating
0.00
-100.00%
4.34
+164.05%
1.64
0.00
Net Interest Income
0.13
+102.93%
-4.29
-161.13%
-1.64
0.00
Interest Expense
0.00
-100.00%
4.34
+164.05%
1.64
0.00
Interest Income Non Operating
0.13
+161.76%
0.05
0.00
—
Interest Income
0.13
+161.76%
0.05
0.00
—
Other Income Expense
—
—
-7.49
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-10.41
+37.01%
-16.53
-26.48%
-13.07
-1430.40%
-0.85
Net Income From Continuing Operation Net Minority Interest
-10.41
+37.01%
-16.53
-26.48%
-13.07
-1430.40%
-0.85
Net Income From Continuing And Discontinued Operation
-10.41
+37.01%
-16.53
-26.48%
-13.07
-1430.40%
-0.85
Net Income Continuous Operations
-10.41
+37.01%
-16.53
-26.48%
-13.07
-1430.40%
-0.85
Normalized Income
-10.41
+37.01%
-16.53
-196.01%
-5.59
-553.88%
-0.85
Net Income Common Stockholders
-10.41
+37.01%
-16.53
-26.48%
-13.07
-1430.40%
-0.85
Diluted EPS
—
-0.56
-26.85%
-0.44
-1430.39%
-0.03
Basic EPS
—
-0.56
-26.85%
-0.44
-1430.39%
-0.03
Basic Average Shares
—
29.54
-0.24%
29.61
+0.00%
29.61
Diluted Average Shares
—
29.54
-0.24%
29.61
+0.00%
29.61
Diluted NI Availto Com Stockholders
-10.41
+37.01%
-16.53
-26.48%
-13.07
-1430.40%
-0.85
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
7.34
+454.48%
1.32
-72.26%
4.77
+9696.36%
0.05
Current Assets
7.34
+454.48%
1.32
+204.21%
0.44
+793.14%
0.05
Cash Cash Equivalents And Short Term Investments
7.29
+475.51%
1.27
+102753.86%
0.00
-13.25%
0.00
Cash And Cash Equivalents
7.29
+475.51%
1.27
+102753.86%
0.00
-13.25%
0.00
Cash Financial
7.29
+475.51%
1.27
+102753.86%
0.00
-13.25%
0.00
Receivables
—
0.00
-100.00%
0.13
0.00
Prepaid Assets
0.05
-5.50%
0.06
+8016.97%
0.00
0.00
Current Deferred Assets
—
0.00
-100.00%
0.30
+541.04%
0.05
Total Non Current Assets
0.00
0.00
-100.00%
4.34
0.00
Non Current Deferred Assets
—
0.00
-100.00%
4.34
0.00
Total Liabilities Net Minority Interest
1.43
+109.70%
0.68
-49.01%
1.34
+35.45%
0.99
Current Liabilities
1.43
+109.70%
0.68
-49.01%
1.34
+35.45%
0.99
Payables And Accrued Expenses
1.43
+109.70%
0.68
-44.84%
1.23
+25.21%
0.99
Payables
1.01
+48.39%
0.68
-44.84%
1.23
+25.21%
0.99
Accounts Payable
0.54
-8.64%
0.59
-16.92%
0.71
+74.95%
0.40
Current Accrued Expenses
0.42
0.00
—
—
Current Debt And Capital Lease Obligation
—
—
0.10
—
Current Debt
—
—
0.10
—
Total Non Current Liabilities Net Minority Interest
0.00
0.00
0.00
0.00
Stockholders Equity
5.91
+819.60%
0.64
-81.30%
3.44
+466.83%
-0.94
Common Stock Equity
5.91
+819.60%
0.64
-81.30%
3.44
+466.83%
-0.94
Capital Stock
0.00
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
34.38
+15.52%
29.76
+0.52%
29.61
+0.00%
29.61
Ordinary Shares Number
34.38
+15.52%
29.76
+0.52%
29.61
+0.00%
29.61
Additional Paid In Capital
46.92
+50.20%
31.24
+78.49%
17.50
+31722.45%
0.06
Retained Earnings
-41.01
-34.03%
-30.60
-117.55%
-14.06
-1317.36%
-0.99
Total Equity Gross Minority Interest
5.91
+819.60%
0.64
-81.30%
3.44
+466.83%
-0.94
Total Capitalization
5.91
+819.60%
0.64
-81.30%
3.44
+466.83%
-0.94
Working Capital
5.91
+819.60%
0.64
+171.42%
-0.90
+3.94%
-0.94
Invested Capital
5.91
+819.60%
0.64
-81.83%
3.54
+477.60%
-0.94
Total Debt
—
—
0.10
—
Net Debt
—
—
0.10
—
Net Tangible Assets
5.91
+819.60%
0.64
-81.30%
3.44
+466.83%
-0.94
Tangible Book Value
5.91
+819.60%
0.64
-81.30%
3.44
+466.83%
-0.94
Duefrom Related Parties Current
—
0.00
-100.00%
0.13
0.00
Dueto Related Parties Current
0.47
+407.06%
0.09
-82.28%
0.53
-9.35%
0.58
Line Of Credit
—
0.00
-100.00%
0.10
0.00
Other Equity Interest
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-3.69
+27.26%
-5.07
-31.37%
-3.86
-723.58%
-0.47
Cash Flow From Continuing Operating Activities
-3.69
+27.26%
-5.07
-31.37%
-3.86
-723.58%
-0.47
Net Income From Continuing Operations
-10.41
+37.01%
-16.53
-26.48%
-13.07
-1430.40%
-0.85
Other Non Cash Items
—
4.47
+177.30%
1.61
—
Stock Based Compensation
6.13
-10.73%
6.87
0.00
—
Operating Gains Losses
—
—
7.49
—
Change In Working Capital
0.59
+370.22%
0.13
+11.09%
0.11
-70.47%
0.39
Change In Prepaid Assets
0.00
+105.57%
-0.06
-7916.83%
-0.00
0.00
Change In Payables And Accrued Expense
0.37
+99.70%
0.18
+60.30%
0.11
-70.28%
0.39
Change In Other Working Capital
0.22
—
—
—
Financing Cash Flow
9.71
+53.25%
6.34
+64.14%
3.86
+721.05%
0.47
Cash Flow From Continuing Financing Activities
9.71
+53.25%
6.34
+64.14%
3.86
+721.05%
0.47
Net Issuance Payments Of Debt
0.16
+253.98%
-0.10
-106.95%
1.45
+214.11%
0.46
Issuance Of Debt
0.16
0.00
-100.00%
1.45
+214.11%
0.46
Repayment Of Debt
0.00
+100.00%
-0.10
0.00
—
Short Term Debt Issuance
0.16
0.00
-100.00%
1.45
+214.11%
0.46
Short Term Debt Payments
0.00
+100.00%
-0.10
0.00
—
Net Short Term Debt Issuance
0.16
+253.98%
-0.10
-106.95%
1.45
+214.11%
0.46
Net Common Stock Issuance
9.55
+39.81%
6.83
+583.30%
1.00
0.00
Proceeds From Stock Option Exercised
0.00
-100.00%
0.04
0.00
—
Net Other Financing Charges
—
-0.43
-130.84%
1.41
+18201.39%
0.01
Changes In Cash
6.02
+375.97%
1.26
+672919.15%
-0.00
-113.25%
0.00
Beginning Cash Position
1.27
+102753.86%
0.00
-13.25%
0.00
0.00
End Cash Position
7.29
+475.51%
1.27
+102753.86%
0.00
-13.25%
0.00
Free Cash Flow
-3.69
+27.26%
-5.07
-31.37%
-3.86
-723.58%
-0.47
Interest Paid Supplemental Data
0.00
0.00
0.00
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
—
Common Stock Issuance
9.55
+39.81%
6.83
+583.30%
1.00
0.00
Issuance Of Capital Stock
9.55
+39.81%
6.83
+583.30%
1.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category